via Healthline on June 2, 2023
FDA Issues Warning About Off-Brand Versions of Ozempic and Wegovy The FDA has issued a warning about GLP-1 drugs made in compoun
By Julia Ries
David Lebo, PhD, RPh, a professor of pharmaceutical sciences at Temple University’s School of Pharmacy, says that compounding should never be used as a substitute for a commercial product, like Ozempic, unless there are specific reasons such as adjustments to dose, route of administration, ...